Phase II study of cisplatin and 5‐fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185)

MLA

Roland T. Skeel, et al. “Phase II Study of Cisplatin and 5‐fluorouracil in Previously Treated Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study (PA 185).” Breast Cancer Research and Treatment, vol. 57, Sept. 1999, pp. 201–06. EBSCOhost, https://doi.org/10.1023/a:1006229701954.

APA

Roland T. Skeel, Kishan J. Pandya, Martin D. Abeloff, Omer Kucuk, & Howard S. Hochster. (1999). Phase II study of cisplatin and 5‐fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185). Breast Cancer Research and Treatment, 57, 201–206. https://doi.org/10.1023/a:1006229701954

Chicago

Roland T. Skeel, Kishan J. Pandya, Martin D. Abeloff, Omer Kucuk, and Howard S. Hochster. 1999. “Phase II Study of Cisplatin and 5‐fluorouracil in Previously Treated Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study (PA 185).” Breast Cancer Research and Treatment 57 (September): 201–6. doi:10.1023/a:1006229701954.